Abstract. The SARS-CoV-2 pandemic has profoundly affected the social fabric and the economic and health care viability and functioning of most countries. Aside from its deeply destructive impact on health care systems and national economies, the pandemic has jeopardized people’s emotional and psychologicalwell-being as well. The authors aimed to shed a light on how the pandemic has been affecting patients with addiction issues and body dysmorphic disorder (BDD), which is characterized by negative thoughts about appearance and body misperceptions. People with body dysmorphic disorder are in fact at increased risk of developing substance use disorders, and such a destructive association has only been made more severe by pandemic-related restrictions, emotional distress and anxiety, as well aslonger exposure to social media and online interactions. This is a major cause for concern because substance use worsens symptoms of BDD and contributes to unfavorable treatment outcomes.
COVID-19 pandemic, substance use disorders and body image issues, a worrisome correlation
A. SIRIGNANO
Co-primo
;
2022-01-01
Abstract
Abstract. The SARS-CoV-2 pandemic has profoundly affected the social fabric and the economic and health care viability and functioning of most countries. Aside from its deeply destructive impact on health care systems and national economies, the pandemic has jeopardized people’s emotional and psychologicalwell-being as well. The authors aimed to shed a light on how the pandemic has been affecting patients with addiction issues and body dysmorphic disorder (BDD), which is characterized by negative thoughts about appearance and body misperceptions. People with body dysmorphic disorder are in fact at increased risk of developing substance use disorders, and such a destructive association has only been made more severe by pandemic-related restrictions, emotional distress and anxiety, as well aslonger exposure to social media and online interactions. This is a major cause for concern because substance use worsens symptoms of BDD and contributes to unfavorable treatment outcomes.File | Dimensione | Formato | |
---|---|---|---|
291-297.pdf
accesso aperto
Tipologia:
Versione Editoriale
Licenza:
DRM non definito
Dimensione
315.41 kB
Formato
Adobe PDF
|
315.41 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.